Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by Destroyer25on Jun 25, 2021 7:29pm
390 Views
Post# 33454903

Tetra Bio-Pharma Announces Change in Management

Tetra Bio-Pharma Announces Change in ManagementTetra Bio-Pharma Announces Change in Management Canada NewsWire OTTAWA, ON , June 25, 2021 /CNW/ - Tetra Bio-Pharma Inc. ( " Tetra " or the " Company " ) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, announced today that Jean-Franois Boily has resigned as Chief Financial Officer of the Corporation effective July 16 th , 2021 to pursue another business opportunity. Tetra has commenced an executive search for a new Chief Financial Officer. The Company intends to use its internal finance team and to retain the services of a consultant to serve as CFO in order to ensure that all financial reporting obligations of the Company are fulfilled while the Company identifies a suitable candidate to replace Mr. Boily. Tetra will update the market in due course. "On behalf of the Board of Directors, I thank Jean-Franois for his contributions to Tetra over the last 9 months" said Guy Chamberland , Chief Executive Officer of Tetra. "We wish him every success moving forward."
<< Previous
Bullboard Posts
Next >>